Journal ArticleActa Neuropathol Commun · July 2, 2024
The genetic architecture of Parkinson's disease (PD) is complex and multiple brain cell subtypes are involved in the neuropathological progression of the disease. Here we aimed to advance our understanding of PD genetic complexity at a cell subtype precisi ...
Full textLink to itemCite
Journal ArticleClin Neurophysiol · June 2024
OBJECTIVE: Tetanic stimulation of a peripheral nerve prior to transcranial electrical stimulation (TES) may enhance motor evoked potential (MEP) amplitudes. The purpose of this study was to investigate the post-tetanic MEP (p-MEP) technique in improving ME ...
Full textLink to itemCite
Journal ArticleAlzheimer's and Dementia: Translational Research and Clinical Interventions · January 1, 2024
INTRODUCTION: Phase 3 trials using the anti-amyloid antibodies aducanumab, lecanemab, donanemab, and high-dose gantenerumab in prodromal and mild Alzheimer's disease dementia were heterogeneous in respect to statistical significance of effects. However, he ...
Full textCite
Journal ArticleAlzheimers Dement · September 2023
BACKGROUND: Short structural variants (SSVs), including insertions/deletions (indels), are common in the human genome and impact disease risk. The role of SSVs in late-onset Alzheimer's disease (LOAD) has been understudied. In this study, we developed a bi ...
Full textLink to itemCite
Journal ArticleBiomolecules · July 8, 2023
(1) Background: Despite the existence of well-established, CSF-based biomarkers such as amyloid-β and phosphorylated-tau, the pathways involved in the pathophysiology of Alzheimer's disease (AD) remain an active area of research. (2) Methods: We measured 3 ...
Full textLink to itemCite
Journal ArticleJ Clin Neuromuscul Dis · June 1, 2023
OBJECTIVE: Clenbuterol, a beta-agonist, has plausible mechanisms for treating amyotrophic lateral sclerosis (ALS). In this highly inclusive open-label trial (NCT04245709), we aimed to study the safety and efficacy of clenbuterol in patients with ALS. METHO ...
Full textLink to itemCite
ConferenceMuscle Nerve · April 2023
INTRODUCTION/AIMS: The Duke Myasthenia Gravis (MG) Clinic Registry contains comprehensive physician-derived data on patients with MG seen in the Duke MG Clinic since 1980. The aim of this study was to report outcomes in patients seen in the clinic and trea ...
Full textLink to itemCite
Journal ArticleAmyotroph Lateral Scler Frontotemporal Degener · February 2023
We previously reported on a series of patients diagnosed with ALS whom had an extraordinary course defined by substantial and sustained improvement in weakness and function. For this study, twenty-five of these "ALS Reversals" completed extensive environme ...
Full textLink to itemCite
Journal ArticleMov Disord · January 2023
BACKGROUND: Writer's cramp (WC) dystonia is a rare disease that causes abnormal postures during the writing task. Successful research studies for WC and other forms of dystonia are contingent on identifying sensitive and specific measures that relate to th ...
Full textOpen AccessLink to itemCite
Journal ArticleMult Scler Relat Disord · January 2023
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neurological disorder associated with antibodies to aquaporin-4 (AQP4). NMOSD has been thought to follow a progressive disease course, with step-wise accumulation of disability ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Alzheimers Dis · 2023
BACKGROUND: Alzheimer's disease (AD) is a common neurodegenerative disease and mild cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies showed that changes in the neurotrophin signaling pathway could lead to cognitive de ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Prev Alzheimers Dis · 2023
BACKGROUND: The 523 poly-T length polymorphism (rs10524523) in TOMM40 has been reported to influence longitudinal cognitive test performance within APOE ε3/3 carriers. The results from prior studies are inconsistent. It is also unclear whether specific APO ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Neuroimmunol · December 15, 2022
BACKGROUND/INTRODUCTION: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a chronic demyelinating disorder that has been increasingly recognized since the serum antibody became commercially available in 2017. The most common clini ...
Full textOpen AccessLink to itemCite
Journal ArticleBiomolecules · November 12, 2022
Depression is common among late-onset Alzheimer's Disease (LOAD) patients. Only a few studies investigated the genetic variability underlying the comorbidity of depression in LOAD. Moreover, the epigenetic and transcriptomic factors that may contribute to ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · November 2022
This perspective is a companion to a recent editorial on the use of Bayesian analysis in clinical research. We aim to introduce and highlight the relevance and advantages that Bayesian inference offers to clinical trials using the data on the amyloid antib ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · November 2022
The increasing global prevalence of dementia demands concrete actions that are aimed strategically at optimizing processes that drive clinical innovation. The first step in this direction requires outlining hurdles in the transition from research to practi ...
Full textLink to itemCite
Journal ArticleJ Gerontol A Biol Sci Med Sci · September 1, 2022
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, and previous studies have shown its association with accelerated aging. In this study, we hypothesized that single nucleotide polymorphisms (SNPs) that contributed to aging acceleration ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Neurophysiol · July 1, 2022
PURPOSE: In neurophysiologic intraoperative monitoring, double train transcranial electrical stimulation (dt-TES) for motor evoked potentials (MEP) consists of an initial, facilitating train of stimuli followed by a second, testing, train. The optimal numb ...
Full textLink to itemCite
Journal ArticleNeurobiol Aging · January 2022
The Apolipoprotein E ε4 (APOE ε4) haplotype is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). The Translocase of Outer Mitochondrial Membrane-40 (TOMM40) gene maintains cellular bioenergetics, which is disrupted in AD. TOMM40 rs ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement (N Y) · 2022
INTRODUCTION: As new late-onset Alzheimer's disease (LOAD) genetic risk loci are identified and brain cell-type specific omics data becomes available, there is an unmet need for a bioinformatics framework to prioritize genes and variants for testing in sin ...
Full textLink to itemCite
Journal ArticleFront Neurosci · 2022
INTRODUCTION: Depression is a common, though heterogenous, comorbidity in late-onset Alzheimer's Disease (LOAD) patients. In addition, individuals with depression are at greater risk to develop LOAD. In previous work, we demonstrated shared genetic etiolog ...
Full textOpen AccessLink to itemCite
Journal ArticleAlzheimers Dement · December 2021
BACKGROUND: The Apolipoprotein E ε4 (APOE ε4) haplotype is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). The Translocase of Outer Mitochondrial Membrane-40 (TOMM40) gene maintains cellular bioenergetics, which is disrupted in A ...
Full textLink to itemCite
Journal ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association · December 1, 2021
BACKGROUND: SNPs associated with C-reactive protein (CRP) and plasma lipids have been investigated for polygenic overlap with Alzheimer's disease (AD) risk SNPs. Previously, we reported pleiotropic effects between SNPs associated with cognitive impairment ...
Full textCite
Journal ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association · December 1, 2021
BACKGROUND: As new LOAD genetic risk loci are identified and more brain cell-type specific omics data becomes available, there is an unmet need for a bioinformatics framework to prioritize genes and variants for testing in single-cell molecular profiling e ...
Full textCite
Journal ArticleNeurohospitalist · October 2021
BACKGROUND AND PURPOSE: Rates of emergency medical services (EMS) utilization for acute stroke remain low nationwide, despite the time-sensitive nature of the disease. Prior research suggests several demographic and social factors are associated with EMS u ...
Full textLink to itemCite
Journal ArticleJournal of Neuroanaesthesiology and Critical Care · September 1, 2021
Aim Patients with mechanical heart valves and coexisting atrial fibrillation (AFib-MHV) who suffer an intraparenchymal hemorrhage (IPH, defined as bleeding solely within the brain parenchyma and/or ventricle) are at a high risk of thromboembolism without a ...
Full textCite
Journal ArticleAlzheimers Dement · August 2021
INTRODUCTION: The goal was to investigate effects of APOE-TOMM40-'523 haplotypes on cognitive decline in non-demented non-Hispanic Blacks (NHB), and determine whether effects differ from non-Hispanic Whites (NHW). METHODS: The impact of zero to two copies ...
Full textLink to itemCite
Journal ArticleLancet Neurol · July 2021
BACKGROUND: The identification of people at risk of cognitive impairment is essential for improving recruitment in secondary prevention trials of Alzheimer's disease. We aimed to test and qualify a biomarker risk assignment algorithm (BRAA) to identify par ...
Full textLink to itemCite
Journal ArticleClin Nutr · May 2021
OBJECTIVE: To exam the association of cognitive decline with APOE ε4 allele carriage and dietary protein intake and investigate whether there is a gene-diet (GxD) interaction of APOE ε4 allele carriage and dietary protein intake on cognitive decline in a n ...
Full textLink to itemCite
Journal ArticleJ Stroke Cerebrovasc Dis · April 2021
OBJECTIVES: Intracerebral hemorrhage comprises a large proportion of inter-hospital transfers to comprehensive stroke centers from centers without comprehensive stroke center resources despite lack of mortality benefit and low comprehensive stroke center r ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · April 2021
INTRODUCTION: The study of Alzheimer's disease (AD) has revealed biological pathways with implications for disease neuropathology and pathophysiology. These pathway-level effects may also be mediated by individual characteristics or covariates such as age ...
Full textLink to itemCite
Journal ArticleSci Rep · January 18, 2021
Stroke is a devastating complication of left ventricular assist device (LVAD) therapy. Understanding the characteristics, risk factors and outcomes of strokes associated with the centrifugal flow LVADs is important to devise better strategies for managemen ...
Full textLink to itemCite
Journal ArticleJ Alzheimers Dis · 2021
BACKGROUND: APOE4 has been hypothesized to increase Alzheimer's disease risk by increasing neuroinflammation, though the specific neuroinflammatory pathways involved are unclear. OBJECTIVE: Characterize cerebrospinal fluid (CSF) proteomic changes related t ...
Full textLink to itemCite
Journal ArticleFront Aging Neurosci · 2021
Background: Both leisure activities and the ε4 allele of the apolipoprotein E (APOE ε4) have been shown to affect cognitive health. We aimed to determine whether engagement in leisure activities protects against APOE ε4-related cognitive decline. Methods: ...
Full textLink to itemCite
Journal ArticleJ Alzheimers Dis · 2021
BACKGROUND: Mild cognitive impairment (MCI) is a heterogeneous condition and MCI patients are at increased risk of progression to dementia due to Alzheimer's disease (AD). OBJECTIVE: In this study, we aim to evaluate the associations between polygenic risk ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Rep · November 5, 2020
In this study, we split 2156 individuals from the Chinese Longitudinal Healthy Longevity Survey (CLHLS) data into two groups, establishing a phenotype of exceptional longevity & normal cognition versus cognitive impairment. We conducted a genome-wide assoc ...
Full textLink to itemCite
Journal ArticleAging Ment Health · September 2020
Background: A small but growing body of evidence supports a relationship between neighborhood socioeconomic status (NSES) and cognitive decline. Additional work is needed to characterize this relationship controlling for risk factors such as cardiovascular ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · September 2020
INTRODUCTION: Late-onset Alzheimer's disease (LOAD) manifests comorbid neuropsychiatric symptoms and posttraumatic stress disorder (PTSD) is associated with an increased risk for dementia in late life, suggesting the two disorders may share genetic etiolog ...
Full textOpen AccessLink to itemCite
Journal ArticleNeurol Genet · August 2020
OBJECTIVE: To test the hypothesis that rs573116164 will have disease-modifying effects in patients with superoxide dismutase 1 (SOD1) familial amyotrophic lateral sclerosis (fALS), we characterized rs573116164 within a cohort of 190 patients with fALS and ...
Full textLink to itemCite
Journal ArticleJ Gerontol B Psychol Sci Soc Sci · March 9, 2020
OBJECTIVES: Genetic risks for cognitive decline are not modifiable; however their relative importance compared to modifiable factors is unclear. We used machine learning to evaluate modifiable and genetic risk factors for Alzheimer's disease (AD), to predi ...
Full textLink to itemCite
Journal ArticleTransl Psychiatry · March 9, 2020
Patients with late-onset Alzheimer's disease (LOAD) frequently manifest comorbid neuropsychiatric symptoms with depression and anxiety being most frequent, and individuals with major depressive disorder (MDD) have an increased prevalence of LOAD. This sugg ...
Full textLink to itemCite
Journal ArticleNeurobiol Aging · August 2019
Variants associated with modulation of c-reactive protein (CRP) and plasma lipids have been investigated for polygenic overlap with Alzheimer's disease risk variants. We examined pleiotropic genetic effects on cognitive impairment conditioned on genetic va ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · August 2019
INTRODUCTION: Genome-wide association studies (GWAS) discovered multiple late-onset Alzheimer's disease (LOAD)-associated SNPs and inferred the genes based on proximity; however, the actual causal genes are yet to be identified. METHODS: We defined LOAD-GW ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · January 2019
The new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease has been developed to accelerate drug discovery and offer a common structure and language to construct new Alzheimer's disease conceptual models. ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement (N Y) · 2019
INTRODUCTION: Alzheimer's disease (AD) is a continuum with neuropathologies manifesting years before clinical symptoms; thus, AD research is attempting to identify more disease-modifying approaches to test treatments administered before full disease expres ...
Full textLink to itemCite
Journal ArticleJAMA Netw Open · August 2018
IMPORTANCE: Sex differences in genetic associations with human longevity remain largely unknown; investigations on this topic are important for individualized health care. OBJECTIVE: To explore sex differences in genetic associations with longevity. DESIGN ...
Full textLink to itemCite
Journal ArticleAging (Albany NY) · June 5, 2018
Copy number variations (CNVs) have been shown to cause numerous diseases, however, their roles in human lifespan remain elusive. In this study, we investigate the association of CNVs with longevity by comparing the Han Chinese genomes of long-lived individ ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · May 2018
INTRODUCTION: Characterizing progression in Alzheimer's disease is critically important for early detection and targeted treatment. The objective was to develop a prognostic model, based on multivariate longitudinal markers, for predicting progression-free ...
Full textOpen AccessLink to itemCite
Journal ArticleAlzheimers Dement · May 2018
The TOMM40 poly-T is a polymorphism in intron 6 of the TOMM40 gene, which is adjacent to and in linkage disequilibrium with APOE. Roses et al. identified the association between the length of TOMM40 poly-T with the risk and age of onset of late-onset Alzhe ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · April 2018
INTRODUCTION: We evaluated the association between neighborhood socioeconomic status (NSES) and sleep quality on cognitive decline in the Health and Retirement Study. METHODS: Health and Retirement Study participants (n = 8090), aged 65+ with DNA and multi ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · December 2017
INTRODUCTION: The study investigated the role of neuropathologies in the relationship between TOMM40 '523 genotype and late-life cognitive decline. METHODS: Participants were community-dwelling older persons who had annual cognitive assessments and brain a ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · November 2017
INTRODUCTION: The α-synuclein (SNCA) gene has been implicated in the etiology of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). METHODS: A computational analysis of SNCA 3' untranslated region to identify potential microRNA (miRNA) binding s ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · November 2017
INTRODUCTION: Family history (FH) of Alzheimer's disease (AD) affects mitochondrial function and may modulate effects of translocase of the outer mitochondrial membrane 40 kDa (TOMM40) rs10524523 ('523) poly-T length on memory decline. METHODS: For 912 non ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement (N Y) · November 2017
INTRODUCTION: Dementia is one of the major health threats to our aging society, and Alzheimer's disease (AD) is the leading cause. In Japan, ∼15% of the elderly population has dementia. The apolipoprotein E (APOE) genotype and a polymorphism (rs10524523) i ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · July 2017
It is hypothesized that retrotransposons have played a fundamental role in primate evolution and that enhanced neurologic retrotransposon activity in humans may underlie the origin of higher cognitive function. As a potential consequence of this enhanced a ...
Full textOpen AccessLink to itemCite
Journal ArticleNeurology · February 14, 2017
OBJECTIVE: To interrogate a poly-T variant (rs10524523, '523) in TOMM40, a gene adjacent to the APOE gene on chromosome 19, in older persons with APOE ε3/3 homozygosity for association with cognitive decline, the clinical hallmark of Alzheimer disease (AD) ...
Full textLink to itemCite
Journal ArticlePLoS One · 2017
Patterns of linkage between the ε4 allele of Apolipoprotein E (APOE) and '523 poly-T alleles in the adjacent gene, TOMM40, differ between Caucasian and African Americans. The extent to which this difference affects the risk of Alzheimer's disease (AD) is u ...
Full textLink to itemCite
Journal ArticleExpert Rev Precis Med Drug Dev · 2017
INTRODUCTION: Developing biomarker tools for identification of individuals at high-risk for late-onset Alzheimer's disease (LOAD) is important for prognosis and early treatment. This review focuses on genetic factors and their potential role for precision ...
Full textLink to itemCite
Journal ArticleHum Mutat · September 2016
Short structural variants (SSVs) are short genomic variants (<50 bp) other than SNPs. It has been suggested that SSVs contribute to many human complex traits. However, high-throughput analysis of SSVs presents numerous technical challenges. In order to fac ...
Full textLink to itemCite
Journal ArticleJ Neurol Sci · June 15, 2016
Type II diabetes mellitus (DM) increases risk for cognitive decline and is associated with brain atrophy in older demented and non-demented individuals. We investigated (1) the cross-sectional association between fasting blood glucose level and cortical th ...
Full textLink to itemCite
Journal ArticleRejuvenation Res · June 2016
On the basis of the genotypic/phenotypic data from Chinese Longitudinal Healthy Longevity Survey (CLHLS) and Cox proportional hazard model, the present study demonstrates that interactions between carrying FOXO1A-209 genotypes and tea drinking are signific ...
Full textOpen AccessLink to itemCite
Journal ArticleAlzheimers Dement · June 2016
The methodology of Genome-Wide Association Screening (GWAS) has been applied for more than a decade. Translation to clinical utility has been limited, especially in Alzheimer's Disease (AD). It has become standard practice in the analyses of more than two ...
Full textLink to itemCite
Journal ArticleCurr Neurol Neurosci Rep · May 2016
Clinical trials for Alzheimer's disease are now focusing on the earliest stages of the disease with the goal of delaying dementia onset. There is great utility in using genetic variants to identify individuals at high age-dependent risk when the goal is to ...
Full textLink to itemCite
Journal ArticleSci Rep · February 25, 2016
Only two genome-wide significant loci associated with longevity have been identified so far, probably because of insufficient sample sizes of centenarians, whose genomes may harbor genetic variants associated with health and longevity. Here we report a gen ...
Full textOpen AccessLink to itemCite
Journal ArticleExpert Opin Drug Metab Toxicol · 2016
INTRODUCTION: In this article we discuss several human neurological diseases and their relationship to specific highly polymorphic small structural variants (SVs). Unlike genome-wide association analysis (GWAS), this methodology is not a genome screen to d ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement (N Y) · January 1, 2016
BACKGROUND: A straightforward, reproducible blood-based test that predicts age dependent risk of Alzheimer's disease (AD) could be used as an enrichment tool for clinical development of therapies. This study evaluated the prognostic performance of a geneti ...
Full textLink to itemCite
Journal ArticleInt J Stroke · December 2015
BACKGROUND: Two markers of cerebral small vessel disease are white matter hyperintensities and cerebral microbleeds, which commonly occur in people with Alzheimer's disease. AIM AND/OR HYPOTHESIS: To test for independent associations between two Alzheimer' ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · October 2015
INTRODUCTION: We recently showed that tagging single-nucleotide polymorphisms across the SNCA locus were significantly associated with increased risk for Lewy body (LB) pathology in Alzheimer's disease (AD) cases. However, the actual genetic variant(s) tha ...
Full textLink to itemCite
Journal ArticlePLoS One · 2015
OBJECTIVE: An Alzheimer's disease (AD) diagnosis is preceded by a long period of cognitive decline. We previously demonstrated increased risk of decline among individuals possessing one or more APOE ε4 alleles together with a family history of AD. The obje ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · November 2014
BACKGROUND: Several studies have demonstrated a lower apolipoprotein E4 (APOE ε4) allele frequency in African-Americans, but yet an increased age-related prevalence of AD. An algorithm for prevention clinical trials incorporating TOMM40'523 (Translocase of ...
Full textLink to itemCite
Journal ArticleJ Parkinsons Dis Alzheimers Dis · November 2014
Mitochondrial dysfunction is an important factor in the pathogenesis of age-related diseases, including neurodegenerative diseases like Alzheimer's and Parkinson's spectrum disorders. A polymorphism in Translocase of the Outer Mitochondrial Membrane - 40 k ...
Full textLink to itemCite
Journal ArticleTransl Psychiatry · September 23, 2014
Genetic polymorphisms in the APOE ɛ and TOMM40 '523' poly-T repeat gene loci have been associated with significantly increased risk of Alzheimer's disease. This study investigated the independent effects of these polymorphisms on human cognitive ageing, an ...
Full textLink to itemCite
Journal ArticleHum Mol Genet · September 15, 2014
The molecular genetic basis that leads to Lewy Body (LB) pathology in 15-20% of Alzheimer disease cases (LBV/AD) was largely unknown. Alpha-synuclein (SNCA) and Leucine-rich repeat kinase2 (LRRK2) have been implicated in the pathogenesis of Parkinson's dis ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · September 2014
BACKGROUND: We investigated the genomic region spanning the Translocase of the Outer Mitochondrial Membrane 40-kD (TOMM40) and Apolipoprotein E (APOE) genes, that has been associated with the risk and age of onset of late-onset Alzheimer's disease (LOAD) t ...
Full textLink to itemCite
Journal ArticleEur Neuropsychopharmacol · September 2014
The variable length poly-T, rs10524523 ('523') located within the TOMM40 gene, was recently associated with several phenotypes of cognitive function. The short (S) allele is associated with later AD onset age and better cognitive performance, compared to t ...
Full textLink to itemCite
Journal ArticleNeurobiol Aging · June 2014
Apolipoprotein E (APOE) ε genotype has previously been significantly associated with cognitive, brain imaging, and Alzheimer's disease-related phenotypes (e.g., age of onset). In the TOMM40 gene, the rs10524523 ("523") variable length poly-T repeat polymor ...
Full textLink to itemCite
Journal ArticleCurr Opin Pharmacol · February 2014
TOMMORROW is a Phase III delay of onset clinical trial to determine whether low doses of pioglitazone, a molecule that induces mitochondrial doubling, delays the onset of MCI-AD in normal subjects treated with low dose compared to placebo. BOLD imaging stu ...
Full textLink to itemCite
Journal ArticleMol Psychiatry · January 2014
Cognitive decline is a feared aspect of growing old. It is a major contributor to lower quality of life and loss of independence in old age. We investigated the genetic contribution to individual differences in nonpathological cognitive ageing in five coho ...
Full textLink to itemCite
Journal ArticleNeuromuscul Disord · December 2013
A polyT repeat in an intronic polymorphism (rs10524523) in the TOMM40 gene, which encodes an outer mitochondrial membrane translocase involved in the transport of amyloid-β and other proteins into mitochondria, has been implicated in Alzheimer's disease an ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · March 2013
A number of recent studies have not replicated the association of the translocase of the outer mitochondrial membrane pore subunit (TOMM40) rs10524523 polymorphism, which is in linkage disequilibrium with apolipoprotein E (APOE), with age of onset of Alzhe ...
Full textLink to itemCite
Journal ArticleClin Pharmacol Ther · February 2013
Curing Alzheimer's disease (AD) remains an elusive goal; indeed, it may even prove to be impossible, given the nature of the disease. Although modulating disease progression is an attractive target and will alleviate the burden of the most severe stages, t ...
Full textLink to itemCite
Journal ArticlePLoS One · 2013
The APOE ε and TOMM40 rs10524523 ('523') variable length poly-T repeat gene loci have been significantly and independently associated with Alzheimer's disease (AD) related phenotypes such as age of clinical onset. Hippocampal atrophy has been significantly ...
Full textLink to itemCite
Book · January 1, 2013
Modern medicine is shifting its focus to predictive and preventive healthcare utilization. To support this change, early intervention clinical trials that delay the onset of symptomatic disease must be conducted in a safe and cost-effective manner, and wit ...
Full textCite
Journal ArticleAlzheimers Dement · November 2012
BACKGROUND: TOMM40 (translocase of the outer mitochondrial membrane pore subunit) is in linkage disequilibrium with apolipoprotein E (APOE). APOE e4 is linked to long (L; 21-29 T residues) poly-T variants within intron 6 of TOMM40, whereas APOE e3 can be a ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · September 2012
INTRODUCTION: A highly polymorphic T homopolymer was recently found to be associated with late-onset Alzheimer's disease risk and age of onset. OBJECTIVE: To explore the effects of the polymorphic polyT tract (rs10524523, referred as '523') on cognitive pe ...
Full textLink to itemCite
Journal ArticleExp Gerontol · May 2012
Neurofilament light (NFL) proteins in cerebrospinal fluid (CSF) are a marker of neuronal damage, especially subcortical axonal injury and white matter disease. Subjects with Alzheimer's disease (AD) have shown elevated levels of CSF NFL as compared to cont ...
Full textLink to itemCite
Journal ArticlePsychoneuroendocrinology · March 2012
Abnormalities of the hypothalamic-pituitary-adrenal (HPA) axis have been reported in subjects with Alzheimer's disease (AD) and may include increased cerebrospinal fluid (CSF) cortisol concentrations. Moreover, presence of the APOE ɛ4 allele, which is an e ...
Full textLink to itemCite
Journal ArticlePLoS One · 2012
We previously discovered that a polymorphic, deoxythymidine-homopolymer (poly-T, rs10524523) in intron 6 of the TOMM40 gene is associated with age-of-onset of Alzheimer's disease and with cognitive performance in elderly. Three allele groups were defined f ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · July 2011
OBJECTIVE: Apolipoprotein E (APOE) genotypes are associated with variable risk of developing late-onset Alzheimer's disease (LOAD), with APOE epsilon 4 (APOE ε4) having higher risk. A variable poly-T length polymorphism at rs10524523, within intron 6 of th ...
Full textLink to itemCite
Journal ArticlePharmacogenomics J · October 2010
The ɛ4 allele of the apolipoprotein E (APOE) gene is currently the strongest and most highly replicated genetic factor for risk and age of onset of late-onset Alzheimer's disease (LOAD). Using phylogenetic analysis, we have identified a polymorphic poly-T ...
Full textLink to itemCite
Journal ArticleEPMA J · June 2010
Alzheimer's disease (AD) presents one of the leading healthcare challenges of the 21st century, with a projected worldwide prevalence of >107 million cases by 2025. While biomarkers have been identified, which may correlate with disease progression or subt ...
Full textLink to itemCite
Journal ArticleAlzheimers Dement · March 2010
This perspective article provides an opportunity to explain a new genetic finding for late-onset Alzheimer's disease (LOAD). It is specifically written for physicians and scientists who are interested in LOAD, but it may be relevant to those interested in ...
Full textLink to itemCite
ConferenceJ Chem Inf Model · 2006
Proton nuclear magnetic resonance (1H NMR) spectroscopic analysis of mixtures has been used extensively for a variety of applications ranging from the analysis of plant extracts, wine, and food to the evaluation of toxicity in animals. For example, NMR ana ...
Full textLink to itemCite
Journal ArticleDrug Discov Today Technol · 2005
Genomic and proteomic platform data constitute a hugely important resource to current efforts in disease understanding, systems biology and drug discovery. We review prerequisites for the adequate management of 'omic' data, the means by which such data are ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · April 2003
Inhibition of human cytomegalovirus (HCMV) by 1263W94 was additive dosewise in combination with ganciclovir, acyclovir, and foscarnet. None of the commonly used anti-human immunodeficiency virus agents antagonized the inhibition of HCMV by 1263W94. The dat ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 2002
Treatment of patients with chronic hepatitis B virus (HBV) infections with potent antiviral therapy often results in dramatic reductions in the levels of viremia to very low levels. Monitoring of serum HBV DNA levels is a consistent method for the assessme ...
Full textLink to itemCite
Chapter · January 1, 2000
The terms bioinformatics and cheminformatics refer to the use of computational methods in the study of biology and chemistry. Information derived from DNA or protein sequences, protein structure, and chemical structure is used to build models of biochemica ...
Full textCite
Journal ArticleJ Infect Dis · December 1999
Hepatitis B viremia and emergence of hepatitis B virus (HBV) YMDD variants with reduced susceptibility to lamivudine were analyzed in patient sera from a phase II study of extended lamivudine therapy. Within 12 weeks, all patients exhibited a marked virolo ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · October 1999
Two novel assays, a restriction fragment length polymorphism (RFLP) assay and an assay based on the 5'-nuclease activity of Taq DNA polymerase, were developed for screening viral variants in lamivudine-treated patients' sera containing <1,000 copies of the ...
Full textLink to itemCite
Book · 1999
Written by two internationally known and well-regarded experts, this book is an essential reference for research and development scientists working in the pharmaceutical and biotechnology industries. ...
Cite
Journal ArticleJ Pharmacol Toxicol Methods · November 1996
A mathematical model of the isometric contraction of cardiac muscle is developed and utilized to characterize the inotropic and lusitropic effects of cardioactive compounds in isolated guinea pig left atria. In contrast to metrics that are based on minima ...
Full textLink to itemCite
Journal ArticleJ Theor Biol · August 21, 1996
Early work in pharmacology characterized the interaction of receptors and ligands in terms of two parameters, affinity and efficacy, an approach we term the bipartite view. A precise formulation of efficacy only exists for very simple pharmacological model ...
Full textLink to itemCite
Journal ArticleJ Pharmacol Exp Ther · July 1996
The activity of a series of busprione analogs at recombinant and rat thoracic aorta alpha-1 adrenoceptors was investigated. Compound affinity for recombinant alpha-1A, alpha-1B and alpha-1D adrenoceptors from human and animal sources was determined by radi ...
Link to itemCite
Journal ArticleJournal of Theoretical Biology · January 21, 1996
In part I of this series of papers, we described the cubic ternary complex (CTC) model. In part II, we examine the pharmacological notion of apparent ligand affinity in the light of this model. The high degree of symmetry that characterizes the CTC model m ...
Full textCite
Journal ArticleJournal of Theoretical Biology · January 21, 1996
In this paper we propose a new equilibrium model of the interactions between receptors, ligands, and G-proteins--the cubic ternary complex (CTC) model. The CTC model is a generalization of the extended ternary complex model of Samama et al. (1993). It inco ...
Full textCite
Journal ArticleDrug Discovery Today · January 1, 1996
Novel methods in molecular biology and advanced technologies have given pharmaceutical research laboratories the capability to test combinatorial libraries rapidly against large numbers of potential targets. Methods to identify optimal assay conditions eff ...
Full textCite
Journal ArticleJ Pharmacol Toxicol Methods · September 1995
Estimates of variance in pharmacological assays are usually made by repeating the experiment with different tissues. Biological factors, such as the inability to wash a drug from tissue, may preclude the type of replication that is appropriate for the stat ...
Full textLink to itemCite
Journal ArticleJ Pharmacol Exp Ther · December 1994
Experiments were designed to characterize the predominant subtype of alpha-1 adrenoceptors in human and canine prostate tissue. The chemical (+/-)-beta-([125I]iodo-4-hydroxyphenyl)-ethyl- aminomethyl-tetralone bound in a specific, saturable manner to a sin ...
Link to itemCite
Journal ArticleJ Pharmacol Exp Ther · November 1994
A simple mathematical model of analgesia in the rat is developed and utilized to determine quantitative structure-activity relationships for a series of novel 4-anilidopiperidine opioids. The compounds tested (selected alkyl carboxyethyl esters attached at ...
Link to itemCite
Journal ArticleJ Med Chem · July 1991
In an effort to discover a potent ultrashort-acting mu opioid analgetic that is capable of metabolizing to an inactive species independent of hepatic function, several classes of 4-anilidopiperidine analgetics were synthesized and evaluated. One series of ...
Full textLink to itemCite
Journal ArticleProceedings - Annual Symposium on Computer Applications in Medical Care · December 1, 1985
A medical information system must be able to meet the demand for new reports. The authors present the advantages and disadvantages of several techniques which allow the user to write medically oriented reports without programming. The TMR report generator ...
Cite
Journal ArticleProceedings - Annual Symposium on Computer Applications in Medical Care · December 1, 1984
Five levels of computer-generated reports are discussed. These reports vary from rigid, predefined formats to flexible formats which require some user sophistication but no computer programming experience. It is noted that as reports become more flexible, ...
Cite